tiprankstipranks
Trending News
More News >
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
Germany Market

Spago Nanomedical AB (7UX) Cash flow

Compare
0 Followers

Spago Nanomedical AB Cash Flow

DE:7UX's free cash flow for Q4 2024 was kr-7.41M. For the 2024 fiscal year, DE:7UX's free cash flow was decreased by kr10.75M and operating cash flow was kr-7.41M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -34.67Mkr -44.91Mkr -38.19Mkr -35.57Mkr -18.77M
Investing Cash Flow
kr -230.00Kkr -506.00Kkr -3.83Mkr -4.63Mkr -6.38M
Financing Cash Flow
kr 22.15Mkr 28.53Mkr 51.66Mkr 64.21Mkr 41.45M
End Cash Position
kr 32.47Mkr 45.22Mkr 62.10Mkr 52.46Mkr 28.45M
Free Cash Flow
kr -34.67Mkr -45.41Mkr -42.02Mkr -40.20Mkr -25.15M
Currency in SEK

Spago Nanomedical AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis